Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region

Antioxidants & Redox Signaling
Naoki OhkuraShuichi Horie

Abstract

Tissue factor pathway inhibitor (TFPI) is a Kunitz-type protease inhibitor that inhibits the initial reactions of blood coagulation. In this study, we explored the nature of active components that reduce the anticoagulant activity of TFPI in oxidized low-density lipoprotein (ox-LDL). The organic solvent-soluble fraction obtained from ox-LDL was fractionated by normal-phase HPLC. The binding profile of each fraction to TFPI showed a single peak eluting near purified oxidized phospholipid. To explore further the components in oxidized phospholipid that inhibit TFPI activity, we used oxidized phospholipids that mimic the biological activity of ox-LDL. The oxidation products of 1- and/or 2-oleoyl phosphatidylcholine or phosphatidylethanolamine were the most potent inhibitors of TFPI activity, whereas those of arachidonyl phosphatidylcholine possessed only a weak inhibitory effect on the TFPI activity. These oxidized phospholipids mainly associated with the C-terminal basic region of the TFPI molecule. The results indicate that oxidation products of delta-9 unsaturated phospholipids are candidate active components of ox-LDL that impair the function of TFPI through specific association with its C-terminal basic region.

References

May 12, 1975·Analytical Biochemistry·T G RedgraveC E West
Jan 1, 1992·Seminars in Thrombosis and Hemostasis·B D WilsonG M Rodgers
Dec 1, 1991·The Journal of Clinical Investigation·J L Witztum, D Steinberg
Jul 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J R WeisG M Rodgers
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J N WilcoxD Gordon
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·P AvogaroG Cazzolato
May 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·J CrawleyC Lupu
Feb 13, 2001·The Journal of Nutrition·A AzziJ Zingg
Apr 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Hisao Kato
Nov 1, 2002·Biochemical and Biophysical Research Communications·Sayuri HiraishiYoshiyuki Seyama
Aug 13, 2003·Journal of Thrombosis and Haemostasis : JTH·G J Broze
Oct 17, 2003·Journal of Biochemistry·Hiroyuki ItabeTatsuya Takano
Oct 1, 1997·Trends in Cardiovascular Medicine·A L Schwartz, G J Broze

❮ Previous
Next ❯

Citations

Jul 10, 2004·Antioxidants & Redox Signaling·Agnes Görlach
Aug 24, 2005·Antioxidants & Redox Signaling·Agnes Görlach
Aug 19, 2009·Antioxidants & Redox Signaling·Valery N BochkovJohannes Stöckl
Sep 1, 2012·Circulation Research·Sangderk LeeJudith A Berliner
Oct 15, 2011·American Journal of Respiratory Cell and Molecular Biology·Vitaliy StarostaKonstantin G Birukov
Sep 16, 2009·Free Radical Biology & Medicine·Jane A Leopold, Joseph Loscalzo
May 8, 2008·Free Radical Biology & Medicine·Judith A Berliner, Nima M Gharavi
Jan 10, 2018·Journal of Thrombosis and Haemostasis : JTH·G ObermayerC J Binder
Jan 17, 2020·Pediatric Diabetes·Vibeke BratsethIngebjørg Seljeflot
Jun 19, 2020·International Journal of Molecular Sciences·Qinhong Wang, Rahima Zennadi
Apr 25, 2020·Cells·Pratap Karki, Konstantin G Birukov
Mar 15, 2020·International Journal of Molecular Sciences·Clemens GutmannAlberto Smith
Jan 30, 2021·Blood·Georg ObermayerChristoph J Binder
Oct 8, 2020·Molecular Aspects of Medicine·Ji NieXiawei Wei
May 15, 2021·Blood Reviews·Laura Delvasto-NuñezSacha Zeerleder

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.